Skip to main content

What the FDA labels say about taking them together

Posaconazole and ritonavir

Posaconazole's FDA label of August 3, 2026 names ritonavir in its drug interactions section; the ritonavir label PlainMeds reads does not name posaconazole. The posaconazole label: “Mechanism and Clinical Effect (s); Ritonavir and atazanavir are CYP3A4 substrates and posaconazole increased plasma concentrations of these drugs.”

Check it at the source: the posaconazole FDA label on DailyMed (effective August 3, 2026, Aurobindo Pharma Limited); the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.).

What does the posaconazole label say about ritonavir?

Posaconazole label, drug interactions

Mechanism and Clinical Effect (s); Ritonavir and atazanavir are CYP3A4 substrates and posaconazole increased plasma concentrations of these drugs [see ].

Source: FDA drug label (POSACONAZOLE), Aurobindo Pharma Limited, effective August 3, 2026 (SPL set f8a26673-261c-4e8e-b1e1-9e23aaf7f285), via openFDA; the full label on DailyMed

What does the ritonavir label say about posaconazole?

Ritonavir's label (effective July 23, 2026) does not name posaconazole in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

27Posaconazole generic labelers
7Ritonavir generic labelers
PosaconazoleRitonavir
Labeled forFungal infectionsHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$2.03 per tablet 100 mg tablet$0.607 per tablet 100 mg tablet
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?